Biogen Inc. (NASDAQ: BIIB) reported first quarter 2021 earnings results today.
Total revenues decreased 24% year-over-year to $2.6 billion. On a constant currency basis, revenues fell 25%.
Net income attributable to Biogen amounted to $410 million, or $2.69 per share, compared to $1.4 billion, or $8.08 per share. Adjusted net income was $813 million, or $5.34 per share.
For the full year of 2021, Biogen expects total revenue of $10.45-10.75 billion and adjusted EPS of $17.50-19.00.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Agentforce in focus as Salesforce (CRM) gets ready for Q3 2025 earnings
After delivering mixed results in the first half, Salesforce, Inc. (NYSE: CRM) looks poised to report strong numbers when it publishes third-quarter results next week. The Customer relationship management platform
What to look for when Dollar Tree (DLTR) reports Q3 2024 earnings
Shares of Dollar Tree, Inc. (NASDAQ: DLTR) rose over 5% on Monday. The stock has dropped 27% over the past three months. The discount store chain is scheduled to report
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
